

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 8.30295557 |
| 2 | negative thymic T cell selection (GO:0045060) | 8.16903765 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.79630241 |
| 4 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 7.48365935 |
| 5 | positive thymic T cell selection (GO:0045059) | 7.14485110 |
| 6 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.91504141 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.83002221 |
| 8 | response to interleukin-15 (GO:0070672) | 6.72542477 |
| 9 | thymic T cell selection (GO:0045061) | 6.70804962 |
| 10 | positive T cell selection (GO:0043368) | 6.70709658 |
| 11 | T cell selection (GO:0045058) | 6.33856410 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 6.16012167 |
| 13 | negative regulation of cell killing (GO:0031342) | 6.13273106 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.13273106 |
| 15 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 6.11717322 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.07083933 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.05055736 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.05055736 |
| 19 | cellular response to interleukin-15 (GO:0071350) | 5.85672164 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.69064428 |
| 21 | interferon-gamma production (GO:0032609) | 5.39326738 |
| 22 | tolerance induction (GO:0002507) | 5.30119425 |
| 23 | regulation of T cell tolerance induction (GO:0002664) | 5.24145925 |
| 24 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.19980860 |
| 25 | T cell receptor signaling pathway (GO:0050852) | 5.12730382 |
| 26 | leukocyte aggregation (GO:0070486) | 5.06957584 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.99694186 |
| 28 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.97049680 |
| 29 | positive regulation of interleukin-2 production (GO:0032743) | 4.88709814 |
| 30 | activated T cell proliferation (GO:0050798) | 4.87158834 |
| 31 | T cell migration (GO:0072678) | 4.85004576 |
| 32 | regulation of regulatory T cell differentiation (GO:0045589) | 4.70672323 |
| 33 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.67848981 |
| 34 | positive regulation of granulocyte differentiation (GO:0030854) | 4.58381207 |
| 35 | positive regulation of isotype switching (GO:0045830) | 4.57188337 |
| 36 | * T cell costimulation (GO:0031295) | 4.53744534 |
| 37 | * lymphocyte costimulation (GO:0031294) | 4.46750735 |
| 38 | positive regulation of humoral immune response (GO:0002922) | 4.45509564 |
| 39 | positive regulation of tolerance induction (GO:0002645) | 4.31435104 |
| 40 | regulation of isotype switching (GO:0045191) | 4.22458296 |
| 41 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.19191097 |
| 42 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.12656736 |
| 43 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.10138248 |
| 44 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.08666631 |
| 45 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.08666631 |
| 46 | negative regulation of T cell mediated immunity (GO:0002710) | 4.05273888 |
| 47 | regulation of interleukin-2 production (GO:0032663) | 3.97603454 |
| 48 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.96561744 |
| 49 | positive regulation of B cell mediated immunity (GO:0002714) | 3.94926514 |
| 50 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.94926514 |
| 51 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.91900967 |
| 52 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.91900967 |
| 53 | positive regulation of DNA recombination (GO:0045911) | 3.88165139 |
| 54 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.86879126 |
| 55 | NIK/NF-kappaB signaling (GO:0038061) | 3.77981244 |
| 56 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.76581775 |
| 57 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.75696295 |
| 58 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.74401673 |
| 59 | regulation of tolerance induction (GO:0002643) | 3.72252404 |
| 60 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.64656342 |
| 61 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.63313941 |
| 62 | regulation of B cell mediated immunity (GO:0002712) | 3.60567787 |
| 63 | B cell receptor signaling pathway (GO:0050853) | 3.60449614 |
| 64 | regulation of immunoglobulin production (GO:0002637) | 3.58171105 |
| 65 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.57236272 |
| 66 | regulation of B cell differentiation (GO:0045577) | 3.55620227 |
| 67 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.50357007 |
| 68 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.46842956 |
| 69 | positive regulation of immunoglobulin production (GO:0002639) | 3.45524318 |
| 70 | T cell homeostasis (GO:0043029) | 3.45278796 |
| 71 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.42761380 |
| 72 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.42498352 |
| 73 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.42097067 |
| 74 | T cell differentiation (GO:0030217) | 3.34610439 |
| 75 | alpha-beta T cell differentiation (GO:0046632) | 3.34376903 |
| 76 | positive regulation of B cell differentiation (GO:0045579) | 3.32170469 |
| 77 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.30992367 |
| 78 | Peyers patch development (GO:0048541) | 3.30992367 |
| 79 | alpha-beta T cell activation (GO:0046631) | 3.30839800 |
| 80 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.29944829 |
| 81 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.28453242 |
| 82 | regulation of response to interferon-gamma (GO:0060330) | 3.25252888 |
| 83 | regulation of granulocyte differentiation (GO:0030852) | 3.25096865 |
| 84 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.24881618 |
| 85 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.24830416 |
| 86 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.24729048 |
| 87 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.24648693 |
| 88 | regulation of immunoglobulin secretion (GO:0051023) | 3.22267210 |
| 89 | positive regulation of interleukin-4 production (GO:0032753) | 3.21761707 |
| 90 | detection of bacterium (GO:0016045) | 3.18939298 |
| 91 | regulation of defense response to virus by virus (GO:0050690) | 3.18141192 |
| 92 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.16563864 |
| 93 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.16563864 |
| 94 | T cell proliferation (GO:0042098) | 3.16371460 |
| 95 | T-helper cell differentiation (GO:0042093) | 3.15886484 |
| 96 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.15886484 |
| 97 | positive regulation of cell killing (GO:0031343) | 3.15421672 |
| 98 | natural killer cell differentiation (GO:0001779) | 3.13507413 |
| 99 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.11286007 |
| 100 | lymph node development (GO:0048535) | 3.09941266 |
| 101 | cellular response to interleukin-4 (GO:0071353) | 3.09909215 |
| 102 | mast cell activation (GO:0045576) | 3.09246018 |
| 103 | cellular response to type I interferon (GO:0071357) | 3.09134289 |
| 104 | type I interferon signaling pathway (GO:0060337) | 3.09134289 |
| 105 | T cell activation (GO:0042110) | 3.09119619 |
| 106 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.08626632 |
| 107 | response to type I interferon (GO:0034340) | 3.07818040 |
| 108 | myeloid dendritic cell activation (GO:0001773) | 3.07273707 |
| 109 | T cell lineage commitment (GO:0002360) | 3.07031365 |
| 110 | regulation of alpha-beta T cell activation (GO:0046634) | 3.06911613 |
| 111 | detection of other organism (GO:0098543) | 3.06884801 |
| 112 | cellular extravasation (GO:0045123) | 3.06552013 |
| 113 | lymphocyte migration (GO:0072676) | 3.05510240 |
| 114 | regulation of interleukin-4 production (GO:0032673) | 3.05482724 |
| 115 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.04296167 |
| 116 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.03889915 |
| 117 | myeloid dendritic cell differentiation (GO:0043011) | 3.03602339 |
| 118 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.02362357 |
| 119 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.00551672 |
| 120 | regulation of chronic inflammatory response (GO:0002676) | 2.99904722 |
| 121 | regulation of cell killing (GO:0031341) | 2.99079407 |
| 122 | negative regulation of interleukin-12 production (GO:0032695) | 2.97670286 |
| 123 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.96548860 |
| 124 | * positive regulation of T cell activation (GO:0050870) | 2.95017055 |
| 125 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.94691093 |
| 126 | positive regulation of T cell cytokine production (GO:0002726) | 2.94472079 |
| 127 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.94400324 |
| 128 | leukocyte cell-cell adhesion (GO:0007159) | 2.93567608 |
| 129 | positive regulation of T cell differentiation (GO:0045582) | 2.92451130 |
| 130 | natural killer cell activation (GO:0030101) | 2.92313346 |
| 131 | lymphocyte homeostasis (GO:0002260) | 2.88746358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.14832981 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.05092450 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.68536116 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 4.11747303 |
| 5 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.54985959 |
| 6 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.45478364 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.37989352 |
| 8 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.28832768 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.18760263 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.13193610 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.04712492 |
| 12 | MAF_26560356_Chip-Seq_TH1_Human | 2.98004916 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.91755186 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.78861426 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.72110751 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.66938873 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.61673912 |
| 18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.61516571 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.58078391 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.53568845 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.41246184 |
| 22 | * MAF_26560356_Chip-Seq_TH2_Human | 2.24427980 |
| 23 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.23212510 |
| 24 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.20507241 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.11515171 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.03365914 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.01905812 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.99903971 |
| 29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.95884852 |
| 30 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.94119570 |
| 31 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.83740171 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.80182863 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74127256 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71182196 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65625656 |
| 36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.65517276 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62485368 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58230059 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.57999630 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56012938 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50961642 |
| 42 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43874033 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43845738 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43496687 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.41831930 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37787461 |
| 47 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.36863035 |
| 48 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.36837277 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36159185 |
| 50 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.34913056 |
| 51 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.33999163 |
| 52 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.32651572 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32188267 |
| 54 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.31925784 |
| 55 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28765185 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27174472 |
| 57 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.24319052 |
| 58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23354940 |
| 59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21804305 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20859701 |
| 61 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.20599775 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19995804 |
| 63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18224033 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16207563 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15511655 |
| 66 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.12072421 |
| 67 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08103846 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08011301 |
| 69 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.07699720 |
| 70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07290362 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07134860 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03360677 |
| 73 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03207674 |
| 74 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01614070 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01188707 |
| 76 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99319350 |
| 77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99214859 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97599443 |
| 79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96613666 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95756276 |
| 81 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94297889 |
| 82 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.93656202 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92601450 |
| 84 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89964643 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89555672 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88934588 |
| 87 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.88421252 |
| 88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88109964 |
| 89 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87373111 |
| 90 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.87344896 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86881045 |
| 92 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86827231 |
| 93 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.86248715 |
| 94 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85988850 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85936384 |
| 96 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85275131 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.85172621 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84677942 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84446332 |
| 100 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83236469 |
| 101 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.81457220 |
| 102 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.79194616 |
| 103 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.79028814 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78081486 |
| 105 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.77348854 |
| 106 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.76929511 |
| 107 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.76784367 |
| 108 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.75780567 |
| 109 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.75121870 |
| 110 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.74487741 |
| 111 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74451673 |
| 112 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.73650357 |
| 113 | GATA3_26560356_Chip-Seq_TH1_Human | 0.73478670 |
| 114 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.73423519 |
| 115 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71130209 |
| 116 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.70933714 |
| 117 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.70821439 |
| 118 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.70577116 |
| 119 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.70003631 |
| 120 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69500279 |
| 121 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.69014068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.19414306 |
| 2 | MP0005671_abnormal_response_to | 3.97821555 |
| 3 | MP0000685_abnormal_immune_system | 3.76268737 |
| 4 | MP0001800_abnormal_humoral_immune | 3.13211336 |
| 5 | MP0001790_abnormal_immune_system | 3.08519106 |
| 6 | MP0005387_immune_system_phenotype | 3.08519106 |
| 7 | MP0009333_abnormal_splenocyte_physiolog | 3.08297566 |
| 8 | MP0002166_altered_tumor_susceptibility | 3.05063175 |
| 9 | MP0003436_decreased_susceptibility_to | 2.99357075 |
| 10 | MP0003866_abnormal_defecation | 2.97716398 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.88870519 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.85136255 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.83627902 |
| 14 | MP0002398_abnormal_bone_marrow | 2.81189350 |
| 15 | MP0000703_abnormal_thymus_morphology | 2.80891537 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.76836275 |
| 17 | MP0002405_respiratory_system_inflammati | 2.74845413 |
| 18 | MP0002723_abnormal_immune_serum | 2.69670879 |
| 19 | MP0001873_stomach_inflammation | 2.66672151 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.65498657 |
| 21 | MP0001819_abnormal_immune_cell | 2.60211196 |
| 22 | MP0002006_tumorigenesis | 2.51969197 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.42178854 |
| 24 | MP0002933_joint_inflammation | 2.41745129 |
| 25 | MP0000716_abnormal_immune_system | 2.36347973 |
| 26 | MP0010155_abnormal_intestine_physiology | 2.35596926 |
| 27 | MP0002722_abnormal_immune_system | 2.29985163 |
| 28 | MP0009785_altered_susceptibility_to | 2.28804426 |
| 29 | MP0000689_abnormal_spleen_morphology | 2.25165181 |
| 30 | MP0003303_peritoneal_inflammation | 2.21942811 |
| 31 | MP0006082_CNS_inflammation | 2.19673211 |
| 32 | MP0005025_abnormal_response_to | 2.19552386 |
| 33 | MP0003724_increased_susceptibility_to | 1.98512689 |
| 34 | MP0002429_abnormal_blood_cell | 1.94458133 |
| 35 | MP0004947_skin_inflammation | 1.88976169 |
| 36 | MP0004510_myositis | 1.79005253 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.67944880 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.65993602 |
| 39 | MP0001853_heart_inflammation | 1.63265423 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.59248224 |
| 41 | MP0002419_abnormal_innate_immunity | 1.48355313 |
| 42 | MP0008057_abnormal_DNA_replication | 1.40767643 |
| 43 | MP0004381_abnormal_hair_follicle | 1.39776255 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.35136863 |
| 45 | MP0002277_abnormal_respiratory_mucosa | 1.32602695 |
| 46 | MP0010352_gastrointestinal_tract_polyps | 1.31451491 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.30981061 |
| 48 | MP0005310_abnormal_salivary_gland | 1.26142437 |
| 49 | MP0008961_abnormal_basal_metabolism | 1.24562432 |
| 50 | MP0008260_abnormal_autophagy | 1.19937043 |
| 51 | MP0000490_abnormal_crypts_of | 1.17780497 |
| 52 | MP0000858_altered_metastatic_potential | 1.16327092 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.14652615 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.05230554 |
| 55 | MP0002019_abnormal_tumor_incidence | 1.03692382 |
| 56 | MP0001851_eye_inflammation | 1.02406534 |
| 57 | MP0002254_reproductive_system_inflammat | 1.02176482 |
| 58 | MP0003448_altered_tumor_morphology | 1.01530713 |
| 59 | MP0005076_abnormal_cell_differentiation | 0.99726534 |
| 60 | MP0003077_abnormal_cell_cycle | 0.98777705 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 0.98706961 |
| 62 | MP0002163_abnormal_gland_morphology | 0.96347011 |
| 63 | MP0008469_abnormal_protein_level | 0.94337771 |
| 64 | MP0003693_abnormal_embryo_hatching | 0.90319656 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 0.88232153 |
| 66 | MP0001545_abnormal_hematopoietic_system | 0.88232153 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 0.88182080 |
| 68 | MP0004957_abnormal_blastocyst_morpholog | 0.87637513 |
| 69 | MP0002822_catalepsy | 0.83050010 |
| 70 | MP0005023_abnormal_wound_healing | 0.80788745 |
| 71 | MP0010094_abnormal_chromosome_stability | 0.80722385 |
| 72 | MP0004130_abnormal_muscle_cell | 0.80405543 |
| 73 | MP0003828_pulmonary_edema | 0.78959252 |
| 74 | MP0005075_abnormal_melanosome_morpholog | 0.78830693 |
| 75 | MP0002998_abnormal_bone_remodeling | 0.78435131 |
| 76 | MP0002009_preneoplasia | 0.76872156 |
| 77 | MP0002693_abnormal_pancreas_physiology | 0.72683879 |
| 78 | MP0002132_abnormal_respiratory_system | 0.70904983 |
| 79 | MP0001348_abnormal_lacrimal_gland | 0.69454498 |
| 80 | MP0000604_amyloidosis | 0.67908483 |
| 81 | MP0003111_abnormal_nucleus_morphology | 0.66297716 |
| 82 | MP0004883_abnormal_blood_vessel | 0.66181381 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.65043341 |
| 84 | MP0001663_abnormal_digestive_system | 0.64172092 |
| 85 | MP0000350_abnormal_cell_proliferation | 0.63517387 |
| 86 | MP0004185_abnormal_adipocyte_glucose | 0.63044742 |
| 87 | MP0001881_abnormal_mammary_gland | 0.62788439 |
| 88 | MP0000609_abnormal_liver_physiology | 0.62695489 |
| 89 | MP0000477_abnormal_intestine_morphology | 0.61724053 |
| 90 | MP0003795_abnormal_bone_structure | 0.58661370 |
| 91 | MP0001919_abnormal_reproductive_system | 0.58570093 |
| 92 | MP0000313_abnormal_cell_death | 0.58379599 |
| 93 | MP0005381_digestive/alimentary_phenotyp | 0.57435425 |
| 94 | MP0009763_increased_sensitivity_to | 0.55993910 |
| 95 | MP0008007_abnormal_cellular_replicative | 0.55777218 |
| 96 | MP0001730_embryonic_growth_arrest | 0.54670522 |
| 97 | MP0005166_decreased_susceptibility_to | 0.54383901 |
| 98 | MP0008995_early_reproductive_senescence | 0.53171368 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.51026691 |
| 100 | MP0003453_abnormal_keratinocyte_physiol | 0.50737569 |
| 101 | MP0009764_decreased_sensitivity_to | 0.50613527 |
| 102 | MP0001216_abnormal_epidermal_layer | 0.50291862 |
| 103 | MP0003045_fibrosis | 0.50130761 |
| 104 | MP0000249_abnormal_blood_vessel | 0.49361388 |
| 105 | MP0009115_abnormal_fat_cell | 0.49149322 |
| 106 | MP0003091_abnormal_cell_migration | 0.48587933 |
| 107 | MP0001243_abnormal_dermal_layer | 0.48549406 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.47791815 |
| 109 | MP0009278_abnormal_bone_marrow | 0.46717899 |
| 110 | MP0009840_abnormal_foam_cell | 0.45181361 |
| 111 | MP0000627_abnormal_mammary_gland | 0.43355720 |
| 112 | MP0005379_endocrine/exocrine_gland_phen | 0.42652721 |
| 113 | MP0008058_abnormal_DNA_repair | 0.41927275 |
| 114 | MP0002088_abnormal_embryonic_growth/wei | 0.41221268 |
| 115 | MP0008004_abnormal_stomach_pH | 0.40348383 |
| 116 | MP0001191_abnormal_skin_condition | 0.40029882 |
| 117 | MP0002086_abnormal_extraembryonic_tissu | 0.39674026 |
| 118 | MP0005390_skeleton_phenotype | 0.39580345 |
| 119 | MP0005451_abnormal_body_composition | 0.39465326 |
| 120 | MP0010307_abnormal_tumor_latency | 0.39412118 |
| 121 | MP0002928_abnormal_bile_duct | 0.39235126 |
| 122 | MP0000367_abnormal_coat/_hair | 0.38689426 |
| 123 | MP0008874_decreased_physiological_sensi | 0.37641053 |
| 124 | MP0008569_lethality_at_weaning | 0.36808674 |
| 125 | MP0005535_abnormal_body_temperature | 0.35962144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.90467125 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.56339036 |
| 3 | Stomatitis (HP:0010280) | 5.93920399 |
| 4 | Abnormality of T cells (HP:0002843) | 5.72075578 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 5.71632733 |
| 6 | Panhypogammaglobulinemia (HP:0003139) | 5.33762682 |
| 7 | Combined immunodeficiency (HP:0005387) | 5.28729093 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.28183390 |
| 9 | Recurrent fungal infections (HP:0002841) | 5.19447293 |
| 10 | Recurrent bronchitis (HP:0002837) | 4.88823070 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 4.68438353 |
| 12 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.68438353 |
| 13 | Chronic diarrhea (HP:0002028) | 4.63345680 |
| 14 | IgM deficiency (HP:0002850) | 4.53918220 |
| 15 | Recurrent viral infections (HP:0004429) | 4.52688424 |
| 16 | Eczematoid dermatitis (HP:0000976) | 4.47127838 |
| 17 | Nasal polyposis (HP:0100582) | 4.45624224 |
| 18 | IgG deficiency (HP:0004315) | 4.29415980 |
| 19 | Chronic otitis media (HP:0000389) | 4.24897775 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.12753212 |
| 21 | Abnormality of the fingertips (HP:0001211) | 3.85043234 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.82929648 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 3.81330657 |
| 24 | Recurrent abscess formation (HP:0002722) | 3.74904448 |
| 25 | Pustule (HP:0200039) | 3.73739025 |
| 26 | IgA deficiency (HP:0002720) | 3.67300493 |
| 27 | Abnormality of the nasal mucosa (HP:0000433) | 3.64366389 |
| 28 | B lymphocytopenia (HP:0010976) | 3.62086727 |
| 29 | Abnormality of B cell number (HP:0010975) | 3.62086727 |
| 30 | Joint swelling (HP:0001386) | 3.57082486 |
| 31 | Autoimmune hemolytic anemia (HP:0001890) | 3.52839806 |
| 32 | Abnormality of macrophages (HP:0004311) | 3.47352581 |
| 33 | Abnormality of eosinophils (HP:0001879) | 3.39343796 |
| 34 | Increased IgM level (HP:0003496) | 3.32924797 |
| 35 | Eosinophilia (HP:0001880) | 3.30810316 |
| 36 | Lymphopenia (HP:0001888) | 3.20005310 |
| 37 | Myositis (HP:0100614) | 3.17972541 |
| 38 | Leukocytosis (HP:0001974) | 3.14746025 |
| 39 | Gastrointestinal infarctions (HP:0005244) | 3.12829259 |
| 40 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.12292301 |
| 41 | Thrombocytosis (HP:0001894) | 3.08824076 |
| 42 | Keratoconjunctivitis sicca (HP:0001097) | 3.08279282 |
| 43 | Basal cell carcinoma (HP:0002671) | 3.05508862 |
| 44 | Increased density of long bones (HP:0006392) | 3.05251998 |
| 45 | Prolonged bleeding time (HP:0003010) | 2.99195529 |
| 46 | Hemoptysis (HP:0002105) | 2.93399072 |
| 47 | Granulocytopenia (HP:0001913) | 2.93268050 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.91050824 |
| 49 | Papilledema (HP:0001085) | 2.84822939 |
| 50 | Cheilitis (HP:0100825) | 2.84065969 |
| 51 | Lymphoma (HP:0002665) | 2.75987142 |
| 52 | Bronchitis (HP:0012387) | 2.73019823 |
| 53 | Pulmonary infiltrates (HP:0002113) | 2.70696965 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.66270033 |
| 55 | Agammaglobulinemia (HP:0004432) | 2.64282325 |
| 56 | Persistence of primary teeth (HP:0006335) | 2.61860547 |
| 57 | Gastrointestinal inflammation (HP:0004386) | 2.61737673 |
| 58 | Slow saccadic eye movements (HP:0000514) | 2.60018246 |
| 59 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.59738528 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.58190834 |
| 61 | Increased IgE level (HP:0003212) | 2.55597415 |
| 62 | Vasculitis (HP:0002633) | 2.55501033 |
| 63 | Autoimmune thrombocytopenia (HP:0001973) | 2.52848281 |
| 64 | Thyroiditis (HP:0100646) | 2.43649960 |
| 65 | Hypoplasia of the thymus (HP:0000778) | 2.40820491 |
| 66 | Colitis (HP:0002583) | 2.40743170 |
| 67 | Recurrent sinusitis (HP:0011108) | 2.39598599 |
| 68 | Chest pain (HP:0100749) | 2.37654724 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.37536523 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.37399336 |
| 71 | Hypochromic anemia (HP:0001931) | 2.36459350 |
| 72 | Gingivitis (HP:0000230) | 2.35248403 |
| 73 | Cellulitis (HP:0100658) | 2.28005029 |
| 74 | Recurrent skin infections (HP:0001581) | 2.26587094 |
| 75 | Meningitis (HP:0001287) | 2.24393721 |
| 76 | Arterial thrombosis (HP:0004420) | 2.20300442 |
| 77 | Optic neuritis (HP:0100653) | 2.18596814 |
| 78 | Retrobulbar optic neuritis (HP:0100654) | 2.18596814 |
| 79 | Papilloma (HP:0012740) | 2.13073461 |
| 80 | Verrucae (HP:0200043) | 2.13073461 |
| 81 | Anorexia (HP:0002039) | 2.11974633 |
| 82 | Chronic sinusitis (HP:0011109) | 2.10300245 |
| 83 | Ureteral stenosis (HP:0000071) | 2.09763088 |
| 84 | Fatigue (HP:0012378) | 2.09060894 |
| 85 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.08151913 |
| 86 | Abnormal platelet volume (HP:0011876) | 2.08142213 |
| 87 | Urticaria (HP:0001025) | 2.07246442 |
| 88 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.06836719 |
| 89 | Amaurosis fugax (HP:0100576) | 2.06011261 |
| 90 | Acute hepatic failure (HP:0006554) | 2.04258155 |
| 91 | Gangrene (HP:0100758) | 2.03667284 |
| 92 | Hypochromic microcytic anemia (HP:0004840) | 2.02072297 |
| 93 | Episodic fever (HP:0001954) | 2.01761661 |
| 94 | Microcytic anemia (HP:0001935) | 2.01127961 |
| 95 | Sepsis (HP:0100806) | 1.98880800 |
| 96 | Stomach cancer (HP:0012126) | 1.98467689 |
| 97 | Chronic obstructive pulmonary disease (HP:0006510) | 1.96376050 |
| 98 | Obstructive lung disease (HP:0006536) | 1.96376050 |
| 99 | Encephalitis (HP:0002383) | 1.95929890 |
| 100 | Hepatitis (HP:0012115) | 1.94324212 |
| 101 | Emphysema (HP:0002097) | 1.93807407 |
| 102 | Seborrheic dermatitis (HP:0001051) | 1.92097766 |
| 103 | Abnormality of the pleura (HP:0002103) | 1.89998698 |
| 104 | Restrictive lung disease (HP:0002091) | 1.88341821 |
| 105 | Poikiloderma (HP:0001029) | 1.88205285 |
| 106 | Ureteral obstruction (HP:0006000) | 1.87803642 |
| 107 | Osteomyelitis (HP:0002754) | 1.86083769 |
| 108 | Bronchiectasis (HP:0002110) | 1.85898593 |
| 109 | Epistaxis (HP:0000421) | 1.83526792 |
| 110 | Recurrent otitis media (HP:0000403) | 1.83439924 |
| 111 | Acute myeloid leukemia (HP:0004808) | 1.82715926 |
| 112 | Orchitis (HP:0100796) | 1.82271769 |
| 113 | Abnormality of the endocardium (HP:0004306) | 1.78718370 |
| 114 | Pulmonary embolism (HP:0002204) | 1.76814075 |
| 115 | Trigonocephaly (HP:0000243) | 1.75719167 |
| 116 | Skin ulcer (HP:0200042) | 1.74538367 |
| 117 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.73630086 |
| 118 | Somatic mutation (HP:0001428) | 1.73439977 |
| 119 | Gastrointestinal stroma tumor (HP:0100723) | 1.72934486 |
| 120 | Arthralgia (HP:0002829) | 1.72593233 |
| 121 | Entropion (HP:0000621) | 1.72522330 |
| 122 | Periodontitis (HP:0000704) | 1.70831919 |
| 123 | Dislocated radial head (HP:0003083) | 1.70826772 |
| 124 | Gingival bleeding (HP:0000225) | 1.69732081 |
| 125 | Abnormality of the prostate (HP:0008775) | 1.68724384 |
| 126 | Increased mean platelet volume (HP:0011877) | 1.67603218 |
| 127 | Prominent nose (HP:0000448) | 1.65942811 |
| 128 | Bicuspid aortic valve (HP:0001647) | 1.65698599 |
| 129 | Teleangiectasia of the skin (HP:0100585) | 1.63799960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.99273370 |
| 2 | TXK | 5.84344744 |
| 3 | JAK3 | 4.02995020 |
| 4 | ZAP70 | 3.58335615 |
| 5 | PRPF4B | 3.44055175 |
| 6 | ITK | 3.17278064 |
| 7 | FGFR4 | 3.14046393 |
| 8 | RIPK4 | 2.54407288 |
| 9 | EEF2K | 2.46772741 |
| 10 | STK10 | 2.36487807 |
| 11 | TYK2 | 2.32200199 |
| 12 | MAP3K14 | 2.23812516 |
| 13 | IKBKE | 2.19732620 |
| 14 | NLK | 2.10879670 |
| 15 | FGFR3 | 1.95221692 |
| 16 | CAMKK2 | 1.79602979 |
| 17 | * LCK | 1.76764655 |
| 18 | CAMKK1 | 1.75572455 |
| 19 | GRK6 | 1.65271058 |
| 20 | JAK1 | 1.65024961 |
| 21 | TEC | 1.63917493 |
| 22 | NME2 | 1.63509001 |
| 23 | CDK12 | 1.54162350 |
| 24 | TRIB3 | 1.51508541 |
| 25 | TAOK3 | 1.50941772 |
| 26 | CSK | 1.49001964 |
| 27 | MAP3K10 | 1.47835958 |
| 28 | HCK | 1.47146032 |
| 29 | KDR | 1.42878223 |
| 30 | PKN2 | 1.25603334 |
| 31 | SYK | 1.25582890 |
| 32 | MAP3K7 | 1.24786431 |
| 33 | TESK2 | 1.23995622 |
| 34 | PRKCQ | 1.22393114 |
| 35 | SMG1 | 1.21228897 |
| 36 | TBK1 | 1.20289907 |
| 37 | TSSK6 | 1.19914681 |
| 38 | CHUK | 1.19174333 |
| 39 | PRKCH | 1.18910735 |
| 40 | BTK | 1.18336471 |
| 41 | IKBKB | 1.18280139 |
| 42 | ERN1 | 1.17350133 |
| 43 | TAOK1 | 1.10872601 |
| 44 | EPHA3 | 1.10445461 |
| 45 | SIK2 | 1.05049430 |
| 46 | JAK2 | 1.00846998 |
| 47 | MAPK11 | 1.00415529 |
| 48 | MAP3K13 | 0.99348830 |
| 49 | MARK3 | 0.97740566 |
| 50 | RPS6KA4 | 0.97082563 |
| 51 | LRRK2 | 0.94683916 |
| 52 | TYRO3 | 0.93024158 |
| 53 | MST4 | 0.92456275 |
| 54 | ALK | 0.91917633 |
| 55 | EPHB1 | 0.91893962 |
| 56 | PASK | 0.89209954 |
| 57 | MAP3K1 | 0.87169590 |
| 58 | MAPK12 | 0.83827054 |
| 59 | CLK1 | 0.80827559 |
| 60 | PIM1 | 0.76626149 |
| 61 | FGFR1 | 0.76083041 |
| 62 | MAP2K3 | 0.75076714 |
| 63 | SIK3 | 0.74169544 |
| 64 | MARK2 | 0.72534847 |
| 65 | KIT | 0.70719904 |
| 66 | BRD4 | 0.70113981 |
| 67 | BLK | 0.69544723 |
| 68 | CDK4 | 0.68891283 |
| 69 | MAP3K11 | 0.68463461 |
| 70 | FES | 0.65530607 |
| 71 | PDGFRB | 0.64836714 |
| 72 | TTN | 0.62305132 |
| 73 | TNK2 | 0.59418819 |
| 74 | CDC7 | 0.57806982 |
| 75 | SIK1 | 0.55929013 |
| 76 | TGFBR1 | 0.54747649 |
| 77 | KSR2 | 0.51420203 |
| 78 | MAP3K8 | 0.51015764 |
| 79 | YES1 | 0.49188413 |
| 80 | PDK1 | 0.47805903 |
| 81 | MELK | 0.47455067 |
| 82 | CAMK4 | 0.44186008 |
| 83 | HIPK2 | 0.44033157 |
| 84 | PIM2 | 0.43660608 |
| 85 | SGK2 | 0.43554947 |
| 86 | INSR | 0.42492271 |
| 87 | UHMK1 | 0.41554013 |
| 88 | FGR | 0.41200861 |
| 89 | CDC42BPA | 0.40535882 |
| 90 | NTRK2 | 0.39945788 |
| 91 | PTK6 | 0.39237281 |
| 92 | ROCK2 | 0.38561183 |
| 93 | * LYN | 0.38408061 |
| 94 | RPS6KA5 | 0.37702264 |
| 95 | CHEK1 | 0.37152341 |
| 96 | IRAK1 | 0.36970921 |
| 97 | IGF1R | 0.36462966 |
| 98 | * FYN | 0.36378674 |
| 99 | IRAK4 | 0.36084142 |
| 100 | MAP3K3 | 0.35202263 |
| 101 | NEK6 | 0.34915162 |
| 102 | RPS6KL1 | 0.34567118 |
| 103 | RPS6KC1 | 0.34567118 |
| 104 | RAF1 | 0.33159324 |
| 105 | RET | 0.32869599 |
| 106 | CSF1R | 0.31096163 |
| 107 | CDK6 | 0.31061380 |
| 108 | CDK9 | 0.30555664 |
| 109 | DMPK | 0.29975999 |
| 110 | RPS6KA6 | 0.29844881 |
| 111 | STK38 | 0.28729422 |
| 112 | TAOK2 | 0.28362729 |
| 113 | STK11 | 0.28211501 |
| 114 | PIK3CG | 0.28196345 |
| 115 | PDPK1 | 0.26982862 |
| 116 | BMPR2 | 0.26338721 |
| 117 | MAPK3 | 0.25568423 |
| 118 | MTOR | 0.25014281 |
| 119 | NEK2 | 0.24647038 |
| 120 | MAPKAPK2 | 0.23504450 |
| 121 | STK4 | 0.22561541 |
| 122 | TGFBR2 | 0.22104721 |
| 123 | SGK3 | 0.21976616 |
| 124 | PRKD2 | 0.20292009 |
| 125 | RPS6KA1 | 0.19805327 |
| 126 | MAPK7 | 0.18364514 |
| 127 | FGFR2 | 0.18344112 |
| 128 | ATR | 0.18241883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.47802608 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.30039871 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.65830889 |
| 4 | Measles_Homo sapiens_hsa05162 | 2.93088532 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.84585381 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.70162653 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.55516730 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.43349272 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.22907924 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.11051422 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.07669437 |
| 12 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.99895077 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.97762574 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.81868123 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.78530258 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.78397876 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.59861621 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.59125615 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57909791 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.57517722 |
| 21 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40826506 |
| 22 | Hepatitis B_Homo sapiens_hsa05161 | 1.37065545 |
| 23 | HTLV-I infection_Homo sapiens_hsa05166 | 1.37012645 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35438033 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34719511 |
| 26 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.28829959 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.28258938 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.25625711 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.25420653 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24747519 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22204705 |
| 32 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.18645741 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17678290 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16753403 |
| 35 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.16697823 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15627973 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.13012855 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10439319 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10112263 |
| 40 | Influenza A_Homo sapiens_hsa05164 | 1.08480522 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.07949573 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07862490 |
| 43 | Spliceosome_Homo sapiens_hsa03040 | 1.06247929 |
| 44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.04884223 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01160252 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 0.97745911 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94532955 |
| 48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.93245155 |
| 49 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92040781 |
| 50 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88058845 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.87944810 |
| 52 | Ribosome_Homo sapiens_hsa03010 | 0.86228680 |
| 53 | RNA transport_Homo sapiens_hsa03013 | 0.86164646 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.80896779 |
| 55 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.79132991 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78474025 |
| 57 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.77297757 |
| 58 | RNA degradation_Homo sapiens_hsa03018 | 0.72354182 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70821939 |
| 60 | DNA replication_Homo sapiens_hsa03030 | 0.70254377 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66783162 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.64668738 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64603542 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60932059 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.60543869 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59248403 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59143931 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58999610 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58807670 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.57603101 |
| 71 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56587653 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56230863 |
| 73 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56162485 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55670871 |
| 75 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.55175117 |
| 76 | Malaria_Homo sapiens_hsa05144 | 0.54830093 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54593782 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54501283 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53508371 |
| 80 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.52636559 |
| 81 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51848102 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51806024 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51529753 |
| 84 | Base excision repair_Homo sapiens_hsa03410 | 0.51067315 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51024339 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49965542 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48404602 |
| 88 | Prostate cancer_Homo sapiens_hsa05215 | 0.47798128 |
| 89 | Mismatch repair_Homo sapiens_hsa03430 | 0.47066689 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46878487 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46830342 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46667907 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46585046 |
| 94 | Long-term potentiation_Homo sapiens_hsa04720 | 0.46584335 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44965877 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44558585 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44268168 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.43590220 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43179463 |
| 100 | Glioma_Homo sapiens_hsa05214 | 0.41918995 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.40678643 |
| 102 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.40278232 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38435614 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35841786 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35837566 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35698905 |
| 107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35458986 |
| 108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35003757 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.34949289 |
| 110 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34833821 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33281554 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33040994 |
| 113 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32247225 |
| 114 | Lysine degradation_Homo sapiens_hsa00310 | 0.31801170 |
| 115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31114318 |
| 116 | Cell cycle_Homo sapiens_hsa04110 | 0.29932982 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29663573 |
| 118 | Phagosome_Homo sapiens_hsa04145 | 0.29036718 |
| 119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28983374 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27545263 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27429423 |
| 122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.26878277 |
| 123 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.26465507 |

